These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12015033)

  • 21. Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors.
    VanOosten RL; Earel JK; Griffith TS
    Cancer Gene Ther; 2006 Jun; 13(6):628-32. PubMed ID: 16456549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells.
    Tang X; Sun YJ; Half E; Kuo MT; Sinicrope F
    Cancer Res; 2002 Sep; 62(17):4903-8. PubMed ID: 12208739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol acts as a potent agent sensitizing colon cancer cells to the TRAIL-induced apoptosis.
    Vaculová A; Hofmanová J; Soucek K; Andera L; Kozubík A
    FEBS Lett; 2004 Nov; 577(1-2):309-13. PubMed ID: 15527805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium.
    Yao Q; Wang S; Gambotto A; Glorioso JC; Evans CH; Robbins PD; Ghivizzani SC; Oligino TJ
    Gene Ther; 2003 Jun; 10(12):1055-60. PubMed ID: 12776164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of TNF-related apoptosis-inducing ligand on in vivo graft survival after ex vivo adenovirus-mediated gene transfer to cornea].
    Guo P; Xie LX; Shi WY; Li XX
    Zhonghua Yan Ke Za Zhi; 2003 Jan; 39(1):19-23. PubMed ID: 12760808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRAIL and docosahexaenoic acid cooperate to induce HT-29 colon cancer cell death.
    Vaculová A; Hofmanová J; Andera L; Kozubík A
    Cancer Lett; 2005 Nov; 229(1):43-8. PubMed ID: 16157217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation.
    Shao R; Lee DF; Wen Y; Ding Y; Xia W; Ping B; Yagita H; Spohn B; Hung MC
    Mol Cancer Res; 2005 Apr; 3(4):219-26. PubMed ID: 15831675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
    Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17-Allylamino-17-demethoxygeldanamycin overcomes TRAIL resistance in colon cancer cell lines.
    Vasilevskaya IA; O'Dwyer PJ
    Biochem Pharmacol; 2005 Aug; 70(4):580-9. PubMed ID: 15993848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
    Zhao L; Dong A; Gu J; Liu Z; Zhang Y; Zhang W; Wang Y; He L; Qian C; Qian Q; Liu X
    Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus.
    Griffith TS; Broghammer EL
    Mol Ther; 2001 Sep; 4(3):257-66. PubMed ID: 11545617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.
    Seki N; Hayakawa Y; Brooks AD; Wine J; Wiltrout RH; Yagita H; Tanner JE; Smyth MJ; Sayers TJ
    Cancer Res; 2003 Jan; 63(1):207-13. PubMed ID: 12517799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
    Izeradjene K; Douglas L; Delaney AB; Houghton JA
    Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor-related apoptosis-inducing ligand R2 and increased decoy receptor tumor necrosis factor-related apoptosis-inducing ligand R3.
    Perlman H; Nguyen N; Liu H; Eslick J; Esser S; Walsh K; Moore TL; Pope RM
    Arthritis Rheum; 2003 Nov; 48(11):3096-101. PubMed ID: 14613271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
    Kim DM; Koo SY; Jeon K; Kim MH; Lee J; Hong CY; Jeong S
    Cancer Res; 2003 Feb; 63(3):621-6. PubMed ID: 12566305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The secretable form of trimeric TRAIL, a potent inducer of apoptosis.
    Kim MH; Billiar TR; Seol DW
    Biochem Biophys Res Commun; 2004 Sep; 321(4):930-5. PubMed ID: 15358116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.
    Mohr A; Henderson G; Dudus L; Herr I; Kuerschner T; Debatin KM; Weiher H; Fisher KJ; Zwacka RM
    Gene Ther; 2004 Mar; 11(6):534-43. PubMed ID: 14999225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.
    Baader E; Toloczko A; Fuchs U; Schmid I; Beltinger C; Ehrhardt H; Debatin KM; Jeremias I
    Cancer Res; 2005 Sep; 65(17):7888-95. PubMed ID: 16140959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
    Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
    Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells.
    Malecaze F; Decha A; Serre B; Penary M; Duboue M; Berg D; Levade T; Lubsen NH; Kremer EJ; Couderc B
    Gene Ther; 2006 Mar; 13(5):440-8. PubMed ID: 16251995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.